619 related articles for article (PubMed ID: 16394042)
21. Predictors of vaginal relapse in stage I endometrial cancer.
Mariani A; Dowdy SC; Keeney GL; Haddock MG; Lesnick TG; Podratz KC
Gynecol Oncol; 2005 Jun; 97(3):820-7. PubMed ID: 15894363
[TBL] [Abstract][Full Text] [Related]
22. Relapse and survival in early-stage ovarian cancer.
Lenhard SM; Bufe A; Kümper C; Stieber P; Mayr D; Hertlein L; Kirschenhofer A; Friese K; Burges A
Arch Gynecol Obstet; 2009 Jul; 280(1):71-7. PubMed ID: 19093129
[TBL] [Abstract][Full Text] [Related]
23. Endoluminal resection for sessile neoplasia in the GI tract is associated with a low recurrence rate and a high 5-year survival rate.
Wang AY; Ahmad NA; Zaidman JS; Brensinger CM; Lewis JD; Long WB; Kochman ML; Ginsberg GG
Gastrointest Endosc; 2008 Jul; 68(1):160-9. PubMed ID: 18577483
[TBL] [Abstract][Full Text] [Related]
24. [Clinical analysis of 20 patients with vaginal intraepithelial neoplasia].
Li SM; Zhang WH; Bai P; Li HJ; Zhang R; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2009 Apr; 44(4):277-80. PubMed ID: 19570466
[TBL] [Abstract][Full Text] [Related]
25. Adjunctive high-risk human papillomavirus DNA testing is a useful option for disease risk assessment in patients with negative Papanicolaou tests without an endocervical/transformation zone sample.
Zhao C; Austin RM
Cancer; 2008 Aug; 114(4):242-8. PubMed ID: 18484643
[TBL] [Abstract][Full Text] [Related]
26. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA
Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
[TBL] [Abstract][Full Text] [Related]
27. What percentage of patients with newly diagnosed carcinoma of the prostate are candidates for surveillance? An analysis of the CaPSURE database.
Barocas DA; Cowan JE; Smith JA; Carroll PR;
J Urol; 2008 Oct; 180(4):1330-4; discussion 1334-5. PubMed ID: 18707731
[TBL] [Abstract][Full Text] [Related]
28. Clinical features and risk of recurrence among patients with vaginal intraepithelial neoplasia.
Dodge JA; Eltabbakh GH; Mount SL; Walker RP; Morgan A
Gynecol Oncol; 2001 Nov; 83(2):363-9. PubMed ID: 11606098
[TBL] [Abstract][Full Text] [Related]
29. Mammography surveillance and mortality in older breast cancer survivors.
Lash TL; Fox MP; Buist DS; Wei F; Field TS; Frost FJ; Geiger AM; Quinn VP; Yood MU; Silliman RA
J Clin Oncol; 2007 Jul; 25(21):3001-6. PubMed ID: 17548838
[TBL] [Abstract][Full Text] [Related]
30. Correlates of intent to seek unnecessary pap tests among elderly women.
Zhang Y; Borders TF; Rohrer JE
Womens Health Issues; 2007; 17(6):351-9. PubMed ID: 17936642
[TBL] [Abstract][Full Text] [Related]
31. [Secondary vaginal adenocarcinoma: a clinicopathologic study of 55 cases].
Zhou XR; Du XG
Zhonghua Fu Chan Ke Za Zhi; 1994 May; 29(5):289-91, 318. PubMed ID: 7956554
[TBL] [Abstract][Full Text] [Related]
32. PAP smear after radiation therapy for cervical carcinoma.
Rintala MA; Rantanen VT; Salmi TA; Klemi PJ; Grénman SE
Anticancer Res; 1997; 17(5B):3747-50. PubMed ID: 9427773
[TBL] [Abstract][Full Text] [Related]
33. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
Silva EG; Gershenson DM; Malpica A; Deavers M
Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of gastrointestinal stromal tumors for recurrence rates and patterns of long-term follow-up.
Samiian L; Weaver M; Velanovich V
Am Surg; 2004 Mar; 70(3):187-91; discussion 191-2. PubMed ID: 15055839
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of cervical cancer screening program at a rural community of South Africa.
Hoque M; Hoque E; Kader SB
East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
[TBL] [Abstract][Full Text] [Related]
36. [Cervical cancer screening and associated treatment costs in France].
Bergeron C; Breugelmans JG; Bouée S; Lorans C; Bénard S; Rémy V
Gynecol Obstet Fertil; 2006 Nov; 34(11):1036-42. PubMed ID: 17070085
[TBL] [Abstract][Full Text] [Related]
37. Women with atypical glandular cells: a long-term follow-up study in a high-risk population.
Chhieng DC; Gallaspy S; Yang H; Roberson J; Eltoum I
Am J Clin Pathol; 2004 Oct; 122(4):575-9. PubMed ID: 15487456
[TBL] [Abstract][Full Text] [Related]
38. Ovarian cancer in women with prior hysterectomy.
Davis R; Unger JB
J La State Med Soc; 2003; 155(2):113-5. PubMed ID: 12778998
[TBL] [Abstract][Full Text] [Related]
39. A case-control study of the protective benefit of cervical screening against invasive cervical cancer in NSW women.
Yang B; Morrell S; Zuo Y; Roder D; Tracey E; Jelfs P
Cancer Causes Control; 2008 Aug; 19(6):569-76. PubMed ID: 18286380
[TBL] [Abstract][Full Text] [Related]
40. Differences in screening history, tumour characteristics and survival between women with screen-detected versus not screen-detected cervical cancer in the east of The Netherlands, 1992-2001.
van der Aa MA; Schutter EM; Looijen-Salamon M; Martens JE; Siesling S
Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):204-9. PubMed ID: 18093720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
